Other languages Bairong Inc.

Equities

Delayed Hong Kong S.E. Other stock markets 02:52:15 2024-04-29 EDT			5-day change	1st Jan Change
9.89 ^HKD	+3.78%		+6.80%	-26.78%

04-15	Bairong Inc. Announces the Resignation of Cathryn Xie Jianing as Executive Director	CI
03-25	Bairong's 2023 Profit Jumps as Revenue Surges 31%	MT

Bairong Inc. Announces the Resignation of Cathryn Xie Jianing as Executive Director	04-15
Bairong's 2023 Profit Jumps as Revenue Surges 31%	03-25
Bairong Inc. announces an Equity Buyback for HKD 250 million worth of its shares.	03-25
Bairong Inc. authorizes a Buyback Plan.	03-24
Bairong Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-24
Bairong Inc. Announces Management Changes	11-20
Bairong Inc. Announces Director Changes	23-10-20
Bairong Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-18
Bairong's H1 Attributable Profit More Than Doubles	23-08-23
Bairong Inc. Announces Board and Committee Changes	23-08-22
Bairong Inc. commences an Equity Buyback Plan for 50,267,339 shares, representing 10% of its issued share capital, under the authorization approved on May 16, 2023.	23-05-17
Bairong Swings to Attributable Profit in 2022 on Absence of Fair Value Losses	23-03-23
Bairong Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22
Bairong Expects Swing to Profit in 2022; Shares Climb 9%	23-02-16
Bairong Inc. Provides Earnings Guidance for the Year Ended December 31, 2022	23-02-15
Bairong Inc. Announces Board Changes	23-01-13
Sihuan Pharmaceutical's Biopharmaceutical Unit Closes 580 Million Yuan Round of Financing; Shares Up 4%	23-01-03
ICBC Chief Business Officer Resigns	22-12-11
Bairong's January-September Revenue Climbs 25%	22-11-13
Bairong Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-13

No results for this search